These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27064765)

  • 1. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendations From the U.S. Preventive Services Task Force.
    Ann Intern Med; 2016 Jun; 164(12):. PubMed ID: 27064765
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
    Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP
    Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
    Mora S; Manson JE
    JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Bibbins-Domingo K;
    Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin for Primary Prevention.
    Richman IB; Owens DK
    Med Clin North Am; 2017 Jul; 101(4):713-724. PubMed ID: 28577622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force.
    Whitlock EP; Burda BU; Williams SB; Guirguis-Blake JM; Evans CV
    Ann Intern Med; 2016 Jun; 164(12):826-35. PubMed ID: 27064261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.
    Wynn RL
    Gen Dent; 2012; 60(4):255-8. PubMed ID: 22782034
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.
    Hayden M; Pignone M; Phillips C; Mulrow C
    Ann Intern Med; 2002 Jan; 136(2):161-72. PubMed ID: 11790072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer.
    McNellis RJ; Beswick-Escanlar V
    Am Fam Physician; 2016 Oct; 94(8):661-662. PubMed ID: 27929225
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.
    Hira RS; Kennedy K; Nambi V; Jneid H; Alam M; Basra SS; Ho PM; Deswal A; Ballantyne CM; Petersen LA; Virani SS
    J Am Coll Cardiol; 2015 Jan; 65(2):111-21. PubMed ID: 25593051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Mar; 150(6):396-404. PubMed ID: 19293072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiaggregation: aspirin].
    Eichenberger A; Pontiggia L; Beer JH
    Ther Umsch; 2003 Jan; 60(1):15-8. PubMed ID: 12638472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease: Shared Decision Making in Clinical Practice.
    Mora S; Ames JM; Manson JE
    JAMA; 2016 Aug; 316(7):709-10. PubMed ID: 27323335
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries for patients. The cost-effectiveness of aspirin, statins, or both drugs in the primary prevention of heart disease.
    Ann Intern Med; 2006 Mar; 144(5):I29. PubMed ID: 16520469
    [No Abstract]   [Full Text] [Related]  

  • 15. Summaries for patients. Aspirin for the prevention of heart attacks in people without previous cardiovascular events: recommendations from the United States Preventive Services Task Force.
    Ann Intern Med; 2002 Jan; 136(2):I55. PubMed ID: 11928737
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
    Dehmer SP; O'Keefe LR; Evans CV; Guirguis-Blake JM; Perdue LA; Maciosek MV
    JAMA; 2022 Apr; 327(16):1598-1607. PubMed ID: 35471506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should This Patient Receive Aspirin?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Burns RB; Graham K; Sawhney MS; Reynolds EE
    Ann Intern Med; 2017 Dec; 167(11):786-793. PubMed ID: 29204620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin for CV prevention -- for which patients?
    Jackson AN; Hume AL
    J Fam Pract; 2011 Sep; 60(9):518-23. PubMed ID: 21901177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for the Prevention of Cardiovascular Disease and Colorectal Cancer: New Recommendations from the USPSTF.
    Owens DK
    Am Fam Physician; 2017 Feb; 95(4):222-223. PubMed ID: 28290628
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.